{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:08:11Z","timestamp":1792681691229,"version":"4.5.0"},"reference-count":25,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CH"],"published-print":{"date-parts":[[2021,4,24]]},"abstract":"<jats:p>AIM: The aim of this study was to assess the success of irreversible electroporation (IRE) in prostate cancer and to differentiate between reactive changes and tumor. MATERIAL AND METHODS: This is a retrospective pilot study of 50 patients after irreversible electroporation (IRE) in prostate cancer between 50\u201379 years (mean age 65 years). Each patient received a transabdominal sonography using a 1\u20136 MHz convex matrix probe. Contrast-enhanced ultrasound (CEUS) was performed after i.v. bolus injection of 2.0\u200aml sulphur hexafluoride microbubbles. DICOM loops were continuously stored up to one minute. Parametric images were calculated by integrated perfusion analysis software. A comparison was drawn to a follow-up MRI six months after ablation. RESULTS: While 13 patients showed local recurrence, 37 patients were successfully treated, meaning no local recurrence within six months after ablation. 18 patients showed signs of prostatitis after IRE. Tumorous changes were visually characterized by dynamic early nodular hypervascularization with fast and high wash-in. Correspondingly, nodular red and yellow shades were seen in parametric imaging. All patients with remaining tumor were correctly identified with CEUS and parametric imaging. After IRE there is a relevant decrease in tumor microcirculation in all patients, as seen in more purple shades of the prostate. The sensitivity for detecting residual tumor with CEUS compared to MRI was 76%, the specificity was 81%. The corresponding positive predictive value (PPV) was 73% and the negative predictive value (NPV) was 83%. CONCLUSION: CEUS and parametric imaging enable a critical analysis of post-ablation defects after IRE for prostate cancer even with a transabdominal approach. Remaining tumor can be detected with the help of pseudo-colors.<\/jats:p>","DOI":"10.3233\/ch-201000","type":"journal-article","created":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T12:31:29Z","timestamp":1608035489000},"page":"303-310","source":"Crossref","is-referenced-by-count":18,"title":["Contrast enhanced ultrasound (CEUS) with parametric imaging after irreversible electroporation (IRE) of the prostate to assess the success of prostate cancer treatment"],"prefix":"10.1177","volume":"77","author":[{"given":"Ernst Michael","family":"Jung","sequence":"first","affiliation":[{"name":"Department of Radiology, University Hospital Regensburg, Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Engel","sequence":"additional","affiliation":[{"name":"Department of Radiology, University Hospital Regensburg, Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Wiggermann","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Klinikum Braunschweig, Braunschweig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Schicho","sequence":"additional","affiliation":[{"name":"Department of Radiology, University Hospital Regensburg, Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Lerchbaumer","sequence":"additional","affiliation":[{"name":"Deparment of Radiology, Charit\u00e9 University Medicine, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Stroszczynski","sequence":"additional","affiliation":[{"name":"Department of Radiology, University Hospital Regensburg, Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Fischer","sequence":"additional","affiliation":[{"name":"Deparment of Radiology, Charit\u00e9 University Medicine, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Wiesinger","sequence":"additional","affiliation":[{"name":"Department of Neuroradiology, medbo Bezirksklinikum Regensburg, Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"issue":"2","key":"10.3233\/CH-201000_ref1","first-page":"87","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"3","key":"10.3233\/CH-201000_ref2","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.purol.2016.12.010","article-title":"[Robot assisted radical prostatectomy: What are the evidences at the time of a specific funding?]","volume":"27","author":"Long","year":"2017","journal-title":"Prog Urol"},{"issue":"9","key":"10.3233\/CH-201000_ref3","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1111\/j.1464-410X.2010.09975.x","article-title":"Focal therapy in the management of localized prostate cancer","volume":"107","author":"Nguyen","year":"2011","journal-title":"BJU Int"},{"issue":"1","key":"10.3233\/CH-201000_ref4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3233\/CH-199222","article-title":"Follow-up after focal therapy of the prostate with high intensity focused ultrasound (HIFU) using contrast enhanced ultrasound (CEUS) in combination with MRI image fusion","volume":"73","author":"Apfelbeck","year":"2019","journal-title":"Clinical Hemorheology and Microcirculation"},{"issue":"3","key":"10.3233\/CH-201000_ref5","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3233\/CH-180423","article-title":"The accuracy of prostate lesion localization in cognitive fusion","volume":"74","author":"Xu","year":"2020","journal-title":"Clinical Hemorheology and Microcirculation"},{"issue":"1","key":"10.3233\/CH-201000_ref6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3233\/CH-199223","article-title":"Detection of Gleason 6 prostate cancer in patients with clinically significant prostate cancer on multiparametric magnetic resonance imaging","volume":"73","author":"Chaloupka","year":"2019","journal-title":"Clinical Hemorheology and Microcirculation"},{"issue":"1","key":"10.3233\/CH-201000_ref7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3233\/CH-199221","article-title":"Quantitative perfusion analysis of hepatocellular carcinoma using dynamic contrast enhanced ultrasound (CEUS) to determine tumor microvascularization","volume":"73","author":"Schaible","year":"2019","journal-title":"Clinical Hemorheology and Microcirculation"},{"issue":"8","key":"10.3233\/CH-201000_ref8","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00117-017-0251-x","article-title":"[Irreversible electroporation (IRE): A minimally invasive therapeutic option in prostate cancer]","volume":"57","author":"Wiggermann","year":"2017","journal-title":"Der Radiologe"},{"issue":"3","key":"10.3233\/CH-201000_ref9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1053\/j.tvir.2015.06.005","article-title":"Focal Therapy of Prostate Cancer Using Irreversible Electroporation","volume":"18","author":"Valerio","year":"2015","journal-title":"Tech Vasc Interv Radiol"},{"issue":"4","key":"10.3233\/CH-201000_ref10","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.eururo.2013.05.048","article-title":"The role of focal therapy in the management of localised prostate cancer: A systematic review","volume":"66","author":"Valerio","year":"2014","journal-title":"Eur Urol"},{"issue":"3","key":"10.3233\/CH-201000_ref11","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1053\/j.tvir.2015.06.002","article-title":"Introduction to Irreversible Electroporation\u2013Principles and Techniques","volume":"18","author":"Thomson","year":"2015","journal-title":"Tech Vasc Interv Radiol"},{"issue":"3","key":"10.3233\/CH-201000_ref12","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.urolonc.2018.11.008","article-title":"Feasibility and safety of irreversible electroporation (IRE) in patients with small renal masses: Results of a prospective study","volume":"37","author":"Buijs","year":"2019","journal-title":"Urol Oncol"},{"issue":"2","key":"10.3233\/CH-201000_ref13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3233\/CH-151985","article-title":"Percutaneous irreversible electroporation (IRE) of prostate cancer: Contrast-enhanced ultrasound (CEUS) findings","volume":"61","author":"Niessen","year":"2015","journal-title":"Clinical Hemorheology and Microcirculation"},{"key":"10.3233\/CH-201000_ref14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/s12885-016-2332-z","article-title":"Focal vs extended ablation in localized prostate cancer with irreversible electroporation; a multi-center randomized controlled trial","volume":"16","author":"Scheltema","year":"2016","journal-title":"BMC Cancer"},{"issue":"2","key":"10.3233\/CH-201000_ref15","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1148\/radiol.2015151166","article-title":"Irreversible Electroporation versus Radiofrequency Ablation: A Comparison of Local and Systemic Effects in a Small-Animal Model","volume":"280","author":"Bulvik","year":"2016","journal-title":"Radiology"},{"issue":"8","key":"10.3233\/CH-201000_ref17","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s00261-016-0700-4","article-title":"Role of contrast-enhanced ultrasound (CEUS) in evaluation of thermal ablation zone","volume":"41","author":"Lekht","year":"2016","journal-title":"Abdominal radiology (New York)"},{"issue":"2-4","key":"10.3233\/CH-201000_ref18","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3233\/CH-2012-1594","article-title":"First results of endocavity evaluation of the microvascularization of malignant prostate tumors using contrast enhanced ultrasound (CEUS) including perfusion analysis: first results","volume":"52","author":"Jung","year":"2012","journal-title":"Clinical Hemorheology and Microcirculation"},{"issue":"2-4","key":"10.3233\/CH-201000_ref20","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3233\/CH-2012-1615","article-title":"Percutaneous irreversible electroporation (IRE) of hepatic malignant tumours: contrast-enhanced ultrasound (CEUS) findings","volume":"52","author":"Wiggermann","year":"2012","journal-title":"Clinical Hemorheology and Microcirculation"},{"issue":"7","key":"10.3233\/CH-201000_ref21","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1007\/s00330-015-4042-3","article-title":"MRI and contrast-enhanced ultrasound imaging for evaluation of focal irreversible electroporation treatment: results from a phase I-II study in patients undergoing IRE followed by radical prostatectomy","volume":"26","author":"van den Bos","year":"2016","journal-title":"European Radiology"},{"issue":"4","key":"10.3233\/CH-201000_ref22","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.bbrc.2013.05.039","article-title":"Changes of apoptosis in tumor tissues with time after irreversible electroporation","volume":"435","author":"Kim","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.3233\/CH-201000_ref23","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3233\/CH-209202","article-title":"Contrast enhanced ultrasound (CEUS) with parametric imaging and time intensity curve analysis (TIC) for evaluation of the success of prostate arterial embolization (PAE) in cases of prostate hyperplasia","volume":"76","author":"Jung","year":"2020","journal-title":"Clinical Hemorheology and Microcirculation"},{"issue":"9","key":"10.3233\/CH-201000_ref24","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.ultrasmedbio.2006.05.031","article-title":"The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations","volume":"32","author":"Piscaglia","year":"2006","journal-title":"Ultrasound in Medicine & Biology"},{"issue":"1-2","key":"10.3233\/CH-201000_ref25","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3233\/CH-189123","article-title":"Contrast enhanced ultrasound (CEUS) with MRI image fusion for monitoring focal therapy of prostate cancer with high intensity focused ultrasound (HIFU)1","volume":"69","author":"Apfelbeck","year":"2018","journal-title":"Clinical Hemorheology and Microcirculation"},{"issue":"16","key":"10.3233\/CH-201000_ref26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta17090","article-title":"Contrast-enhanced ultrasound using SonoVue(R) (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis","volume":"17","author":"Westwood","year":"2013","journal-title":"Health Technol Assess"},{"issue":"3","key":"10.3233\/CH-201000_ref27","first-page":"197","article-title":"[Real-time MRI\/US fusion-guided biopsy improves detection rates of prostate cancer in pre-biopsied patients]","volume":"45","author":"Maxeiner","year":"2014","journal-title":"Aktuelle Urol"}],"container-title":["Clinical Hemorheology and Microcirculation"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/CH-201000","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:04:50Z","timestamp":1777388690000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.medra.org\/servlet\/aliasResolver?alias=iospress&doi=10.3233\/CH-201000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,24]]},"references-count":25,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/ch-201000","relation":{},"ISSN":["1386-0291","1875-8622"],"issn-type":[{"value":"1386-0291","type":"print"},{"value":"1875-8622","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,24]]}}}